Exiting an investment – whether through a public offering or a sale of the company – is an inherently uncertain process. Even for a thriving business with a viable equity story, committed stakeholders ...

The ups and downs of the M&A and financing markets over the past few years, particularly in the emerging companies (EC) and venture capital (VC) sector, have demonstrated the importance of emerging ...

In biotechnology, timing is everything. Whether advancing a novel therapy or scaling a platform, companies often reach a pivotal point: go public or sell. Increasingly, biotech executives are choosing ...